ISPC
iSpecimen Inc.
Key Financials
Net Income
$-10487532
↑ 16.1%
Operating Income
$-8977919
↑ 29.5%
Total Assets
$9.5M
↑ 1.9%
EPS (Diluted)
$-2.28
↑ 87.0%
Cash & Equivalents
$6.9M
↑ 266.3%
Total Liabilities
$6.4M
↑ 6.7%
Shareholders' Equity
$3.1M
↓ 6.7%
Revenue
$1.9M
↓ 79.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/14/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 8-K | 8/7/2026 | View on SEC |
| 424B4 | 8/7/2026 | View on SEC |
| EFFECT | 7/30/2026 | View on SEC |
| S-1/A | 7/17/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| S-1/A | 7/6/2026 | View on SEC |
| S-1 | 6/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ISPC |
| Company Name | iSpecimen Inc. |
| CIK | 1558569 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-301-6700 |